Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells

. 2013 Nov ; 13 (4) : 229-37. [epub] 20120724

Jazyk angličtina Země Itálie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid22825586

Invariant natural killer T (iNKT) cells are CD1d-restricted T cells with regulatory functions. iNKT cells are numerically and functionally deficient in experimental models of type 1 diabetes mellitus (T1DM). Moreover, various experimental strategies correcting the defect of or stimulating iNKT cells prevent T1DM. Here, we review the data on the role of iNKT cells in the development of T1DM and discuss indications, obstacles and prospects of the use of iNKT cell manipulations in the prevention and treatment of human T1DM.

Zobrazit více v PubMed

J Autoimmun. 2004 Dec;23(4):293-300 PubMed

Immunity. 2010 Apr 23;32(4):457-67 PubMed

Nat Rev Immunol. 2010 Jul;10(7):501-13 PubMed

Curr Opin Immunol. 2008 Jun;20(3):358-68 PubMed

J Exp Med. 1995 May 1;181(5):1923-7 PubMed

Nat Med. 2001 Sep;7(9):1052-6 PubMed

J Exp Med. 1998 Apr 6;187(7):1047-56 PubMed

J Immunol. 2002 Jun 15;168(12):6007-11 PubMed

Nature. 1998 Jan 8;391(6663):177-81 PubMed

J Immunol. 2003 Aug 15;171(4):2142-53 PubMed

Eur J Immunol. 2002 Dec;32(12):3657-66 PubMed

Nat Rev Immunol. 2011 Feb;11(2):131-42 PubMed

Physiol Rev. 2011 Jan;91(1):79-118 PubMed

J Exp Med. 2000 Sep 4;192(5):741-54 PubMed

J Immunol. 2001 Mar 15;166(6):3749-56 PubMed

Nat Immunol. 2010 Mar;11(3):197-206 PubMed

J Exp Med. 2001 Dec 17;194(12):1801-11 PubMed

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13838-43 PubMed

Lancet. 1986 Jul 19;2(8499):119-24 PubMed

Int Rev Immunol. 2007 Jan-Apr;26(1-2):49-72 PubMed

J Exp Med. 2001 Dec 17;194(12):1789-99 PubMed

J Exp Med. 2008 Nov 24;205(12):2727-33 PubMed

J Clin Invest. 2008 Oct;118(10):3390-402 PubMed

J Exp Med. 2005 Nov 7;202(9):1279-88 PubMed

J Exp Med. 2002 Mar 4;195(5):637-41 PubMed

Eur J Immunol. 1996 Dec;26(12):2989-98 PubMed

J Immunol. 2004 May 15;172(10):5908-16 PubMed

Nat Rev Immunol. 2003 Mar;3(3):189-98 PubMed

Annu Rev Immunol. 2007;25:297-336 PubMed

Clin Cancer Res. 2002 Dec;8(12):3702-9 PubMed

Scand J Immunol. 2006 Nov;64(5):531-5 PubMed

Clin Exp Immunol. 2007 Apr;148(1):1-16 PubMed

J Exp Med. 2000 Jun 5;191(11):1895-903 PubMed

Eur J Immunol. 2004 Jun;34(6):1723-32 PubMed

J Immunol. 2002 Apr 1;168(7):3251-8 PubMed

J Clin Invest. 2002 Jan;109(1):131-40 PubMed

Curr Opin Immunol. 2011 Dec;23(6):739-45 PubMed

J Leukoc Biol. 2007 Mar;81(3):654-62 PubMed

Semin Immunol. 2010 Apr;22(2):68-78 PubMed

Nat Genet. 2001 Jan;27(1):68-73 PubMed

Nat Rev Immunol. 2005 Jan;5(1):31-42 PubMed

Hum Immunol. 2009 Apr;70(4):262-8 PubMed

Trends Immunol. 2004 Sep;25(9):471-6 PubMed

J Immunol. 2005 Feb 15;174(4):1954-61 PubMed

Diabet Med. 1994 Apr;11(3):299-303 PubMed

J Immunol. 2001 Jan 1;166(1):662-8 PubMed

Diabetes Care. 2002 Oct;25(10):1818-23 PubMed

Cytokine. 2011 Mar;53(3):263-70 PubMed

J Exp Med. 2011 Apr 11;208(4):729-45 PubMed

Diabetes Metab Res Rev. 2009 Nov;25(8):691-3 PubMed

J Clin Invest. 1995 Sep;96(3):1506-11 PubMed

J Immunol Methods. 2001 Jan 1;247(1-2):61-72 PubMed

Curr Opin Immunol. 2003 Dec;15(6):683-9 PubMed

Immunity. 2002 Dec;17(6):725-36 PubMed

J Immunol. 2007 Feb 1;178(3):1415-25 PubMed

Lancet. 2001 Jul 21;358(9277):221-9 PubMed

J Immunol. 2004 Sep 1;173(5):3112-8 PubMed

J Immunol Methods. 2004 Feb 15;285(2):197-214 PubMed

Semin Immunol. 2011 Jun;23(3):182-94 PubMed

J Immunol. 2006 Sep 15;177(6):3695-704 PubMed

Nat Rev Immunol. 2004 Mar;4(3):231-7 PubMed

Clin Immunol. 2011 Aug;140(2):117-8 PubMed

N Engl J Med. 2002 May 30;346(22):1692-8 PubMed

J Immunol. 2005 Aug 15;175(4):2091-101 PubMed

Curr Opin Immunol. 2011 Dec;23(6):746-53 PubMed

J Immunol. 2005 Oct 1;175(7):4458-64 PubMed

J Exp Med. 1998 Nov 16;188(10):1831-9 PubMed

Eur J Immunol. 2011 Dec;41(12):3574-85 PubMed

Immunol Cell Biol. 2009 May-Jun;87(4):315-23 PubMed

Nat Med. 2003 Sep;9(9):1202-8 PubMed

J Clin Invest. 2002 Sep;110(6):793-800 PubMed

J Exp Med. 2007 May 14;204(5):995-1001 PubMed

Diabet Med. 2006 Oct;23(10):1145-50 PubMed

J Exp Med. 2001 Aug 6;194(3):313-20 PubMed

J Immunol. 2006 Dec 15;177(12):8338-47 PubMed

J Immunol. 2005 Feb 1;174(3):1196-204 PubMed

Semin Immunol. 2011 Jun;23(3):214-9 PubMed

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6777-82 PubMed

Diabetes. 1997 Apr;46(4):572-82 PubMed

Immunity. 2010 Apr 23;32(4):468-78 PubMed

Immunology. 2007 Sep;122(1):1-14 PubMed

Science. 1997 Nov 28;278(5343):1626-9 PubMed

J Clin Immunol. 2008 Nov;28(6):677-84 PubMed

Nat Med. 2001 Sep;7(9):1057-62 PubMed

Immunol Cell Biol. 2004 Jun;82(3):247-52 PubMed

Diabetes. 2004 May;53(5):1303-10 PubMed

J Clin Invest. 2003 Oct;112(8):1211-22 PubMed

J Immunol. 2003 Oct 15;171(8):4439-46 PubMed

Diabetes. 2008 Oct;57(10):2693-7 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...